DANIEL PRIETO ROMERO: Open Payments
NPI 1598207300 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,308 in 75 payments from 13 companies in 2025. Trend: 2023 $880 · 2024 $2,381 · 2025 $1,308
Food & beverage: $1,308
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $313 |
| Collegium Pharmaceutical, Inc. | 21 | $284 |
| PFIZER INC. | 12 | $165 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $156 |
| Boston Scientific Corporation | 3 | $117 |
| PROTEGA PHARMACEUTIALS INC | 4 | $115 |
| Atland Pharmaceuticals, LLC | 1 | $33 |
| Globus Medical, Inc. | 1 | $28 |
| Medtronic, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $20 |
Products named: Belbuca, QULIPTA, NURTEC ODT, RELISTOR, ROXYBOND, Intracept, UBRELVY, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE.
Industry payments across FL — which companies pay providers there.
